![]() |
市場調査レポート
商品コード
1754110
血管シーリングデバイス市場レポート:製品別、用途別、エンドユーザー別、地域別、2025年~2033年Vessel Sealing Devices Market Report by Product (Generators, Instruments, Accessories), Application (General Surgery, Laparoscopic Surgery), End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers), and Region 2025-2033 |
||||||
カスタマイズ可能
|
血管シーリングデバイス市場レポート:製品別、用途別、エンドユーザー別、地域別、2025年~2033年 |
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2~3営業日
|
血管シーリングデバイスの世界市場規模は2024年に20億米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに35億米ドルに達し、2025年から2033年にかけて5.77%の成長率(CAGR)を示すと予測しています。同市場は、慢性疾患の有病率の上昇、血管シーリングデバイスを中心とした手術器具の技術進歩、低侵襲手術への嗜好の高まりによって推進されています。
慢性疾患の増加
がん、心血管疾患、肥満などの慢性疾患の頻度が高まっていることが、血管シーリングデバイス市場成長の主な促進要因となっています。これらの疾患は外科的処置を必要とすることが多いため、処置の有効性と安全性を向上させる高度な外科用機器への需要が高まっています。米国疾病管理予防センター(Centers of Diseases Control and Prevention)によると、米国では推定1億2,900万人が心臓病、がん、糖尿病、肥満、高血圧など少なくとも1つの主要な慢性疾患を抱えています。また、米国における主要死因トップ10のうち5つが、予防・治療可能な慢性疾患であるか、あるいは強く関連しています。血管シーリングデバイスは、血管や組織束を一貫して密封し、術中の出血や術後の問題を軽減するため、組織操作や止血を伴う手技において特に重要です。世界中で慢性疾患の負担が増加しており、高齢化も相まって外科的治療の必要性が高まっているため、効果的な血管シーリングソリューションの需要が高まっています。
低侵襲手術の採用増加
血管シーリング装置市場の見通しを良好なものにしているもう一つの重要な要素は、低侵襲手術(MIS)への移行です。国立医学図書館によると、2017年には980万件の入院患者大手術室処置が分析され、そのうち11.1%がMIS、2.5%がロボット支援であったのに対し、2018年には960万件の入院患者手術室処置(11.2%がMIS、2.9%がロボット支援)が分析されました。腹腔鏡手術やロボット手術などの低侵襲手術は、従来の開腹手術に比べて、術後の痛みが少ない、入院期間が短い、回復が早い、合併症の可能性が低いなど、さまざまな利点があります。血管シーリングデバイスは、限られた術野で正確な止血を可能にするため、MIS手術には不可欠です。患者や医療プロバイダーの間で低侵襲手術が普及しているため、高度な血管シーリング技術に対する需要が高まっています。
医療支出の増加
世界の医療支出の増加と医療インフラの継続的な開拓は、血管シーリングデバイス市場の主要促進要因です。Centers for Medicare and Medicaid Servicesによると、米国の医療費は4.1%増で2022年には4兆5,000億米ドルに達し、2021年の3.2%増を上回る。その上、2022年には保険加入率が92%(歴史的な高水準)に達しました。民間医療保険加入者は290万人増加し、メディケイド加入者は610万人増加しました。医療施設に対する政府および民間部門の支出は、特に新興国において、最先端技術を備えた近代的な手術センターの建設につながっています。このような拡大により、高度な外科手術へのアクセシビリティと手ごろな価格が改善され、血管シーリングデバイスの使用が増加しています。さらに、先進国でも発展途上国でも、手術結果の向上と患者の安全性の確保が重視されているため、高性能の手術機器、特に血管シーリング装置の需要が高まっています。
The global vessel sealing devices market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.77% during 2025-2033. The market is propelled by rising prevalence of chronic diseases, technological advancements in surgical instruments, particularly in vessel sealing devices, and the increasing preference for minimally invasive surgeries.
Rising prevalence of chronic diseases
The rising frequency of chronic diseases like cancer, cardiovascular problems, and obesity is a major driver of the vessel sealing devices market growth. As these illnesses frequently require surgical procedures, there is an increased demand for sophisticated surgical equipment that can improve procedural efficacy and safety. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Vessel sealing devices are especially important in procedures involving substantial tissue manipulation and hemostasis because they offer consistent sealing of blood vessels and tissue bundles, reducing intraoperative blood loss and postoperative problems. The growing burden of chronic diseases around the world, combined with the aging population, magnifies the need for surgical treatments, boosting the demand for effective vessel sealing solutions.
Increasing adoption of minimally invasive surgeries
Another key element creating a favorable vascular sealing devices market outlook is the transition to minimally invasive surgical (MIS) procedures. According to National Library of Medicine, in 2017, 9.8 million inpatient major operating room procedures were analyzed, of which 11.1% were MIS and 2.5% were robotic-assisted, compared with 9.6 million inpatient operating room procedures (11.2% MIS and 2.9% robotic-assisted) in 2018. Minimally invasive procedures, such as laparoscopic and robotic surgeries, have various advantages over traditional open surgeries, including less postoperative pain, shorter hospital stays, faster recovery times, and a lower chance of complications. Vessel sealing devices are essential for MIS procedures because they enable precise and successful hemostasis in limited surgical fields. The popularity of minimally invasive operations among patients and healthcare providers has led to increased demand for sophisticated vascular sealing technologies.
Rising healthcare expenditure
Increased healthcare spending and continued development of healthcare infrastructure worldwide are major drivers of the vessel sealing devices market. As per Centers for Medicare and Medicaid Services, U.S. health care spending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Besides, in 2022, the insured share of the population reached 92% (a historic high). Private health insurance enrollment increased by 2.9 million individuals and Medicaid enrollment increased by 6.1 million individuals. Government and private sector expenditures in healthcare facilities, particularly in emerging nations, are leading to the construction of modern surgery centers outfitted with cutting-edge technology. This expansion improves the accessibility and affordability of advanced surgical procedures, increasing the use of vessel sealing devices. Furthermore, the focus on improving surgical results and patient safety in both developed and developing nations encourages the demand for high-performance surgical equipment, particularly vascular sealing devices.
Instruments accounts for the majority of the market share
Vessel sealing instruments are utilized in many different surgical procedures, including general surgery, gynecology, urology, and cardiovascular surgery. Their ability to produce consistent hemostasis and prevent intraoperative blood loss makes them essential in many complex and minimally invasive operations. The adaptability of these devices in handling diverse tissue kinds and sizes, as well as their compatibility with various surgical procedures, broadens their use range. Hence, the increasing number of surgeries is escalating the demand for vessel sealing devices, resulting in a considerable market share. As per data published by National Library of Medicine in 2020, a total of 4642 surgeries were performed per year in India for a population of 88,273. Cataract (22.8%), caesareans (3.8%), surgeries for fractures (3.27%) and hernia (2.86%) were the most common surgeries. Moreover, 44.2% of surgeries belonged to essential surgeries.
Laparoscopic surgery holds the largest share of the industry
Advanced vascular sealing technologies considerably improve the precision and safety of laparoscopic surgery. These technologies enable surgeons to properly and swiftly seal blood arteries and tissue bundles, lowering blood loss and the risk of complications. The exact control over sealing and cutting decreases temperature diffusion to adjacent tissues, which is especially critical in the delicate and limited regions of laparoscopic surgery. This high level of precision drives the widespread adoption of vessel sealing devices in laparoscopic procedures. Besides, technological developments in both laparoscopic equipment and vascular sealing technologies have increased their popularity. Innovative features including integrated cutting and sealing capabilities, ergonomic designs, and improved energy delivery systems have considerably improved the effectiveness of vessel sealing devices.
Hospitals and specialty clinics represent the leading market segment
The rise in chronic diseases is a crucial factor driving the growth of hospitals and specialty clinics. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease such as heart disease, cancer, diabetes, obesity, hypertension. Moreover, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Over the past 2 decades prevalence has increased steadily, and this trend is expected to continue. Chronic conditions such as diabetes, hypertension, cancer, and respiratory diseases require ongoing medical attention, frequent monitoring, and specialized treatments. This has led to a surge in demand for healthcare services and facilities that can manage these conditions effectively. Specialty clinics focusing on diabetes care, oncology, cardiology, and pulmonology are expanding to meet the needs of patients with chronic diseases which in turn is escalating the vessel sealing devices demand.
North America leads the market, accounting for the largest vessel sealing devices market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for vessel sealing devices.
North America, especially he United States, has one of the most advanced healthcare systems in the world. The 2021 World Index on Healthcare Innovation, conducted by the Foundation for Research on Equal Opportunity (FREOPP), ranked the United States in 6th place among the world's healthcare systems. The analysis finds that the United States is a global leader in scientific advancement but that our healthcare system is fiscally unsustainable. The availability of well-equipped hospitals, specialist surgical facilities, and clinics promotes the use of innovative medical technologies, such as vascular sealing devices. Besides, the region's healthcare system invests heavily in cutting-edge equipment and technology, allowing for high-quality surgical care. Moreover, the high healthcare spending, led by both the public and private sectors, enables significant investment in medical technologies and surgical innovations.